FDA inspection
Zhejiang Ausun Pharmaceutical Co., Ltd.: FDA inspection ending Apr 26, 2024
FDA inspection 1239659 · Voluntary Action Indicated (VAI) · Taizhou
Key facts
| Inspection ID | 1239659 |
|---|---|
| Firm | Zhejiang Ausun Pharmaceutical Co., Ltd. |
| FEI number | 3009065969 |
| Address | Zhejiang Chemical Materials Base, No. 5 Donghai 4th Avenue; Linhai Zone |
| City | Taizhou |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Apr 26, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data